BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18279850)

  • 1. Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain.
    Yamamoto W; Mikami T; Iwamura H
    Eur J Pharmacol; 2008 Mar; 583(1):56-61. PubMed ID: 18279850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
    Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M
    Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
    Sain NM; Liang A; Kane SA; Urban MO
    Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
    Valenzano KJ; Tafesse L; Lee G; Harrison JE; Boulet JM; Gottshall SL; Mark L; Pearson MS; Miller W; Shan S; Rabadi L; Rotshteyn Y; Chaffer SM; Turchin PI; Elsemore DA; Toth M; Koetzner L; Whiteside GT
    Neuropharmacology; 2005 Apr; 48(5):658-72. PubMed ID: 15814101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
    Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
    Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
    Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
    Deng L; Cornett BL; Mackie K; Hohmann AG
    Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
    Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
    Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
    Iwamura H; Suzuki H; Ueda Y; Kaya T; Inaba T
    J Pharmacol Exp Ther; 2001 Feb; 296(2):420-5. PubMed ID: 11160626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
    La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
    Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice.
    Jafari MR; Golmohammadi S; Ghiasvand F; Zarrindast MR; Djahanguiri B
    Behav Pharmacol; 2007 Nov; 18(7):691-7. PubMed ID: 17912054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
    Brownjohn PW; Ashton JC
    Neuroscience; 2012 Feb; 203():180-93. PubMed ID: 22210507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.
    Beltramo M; Bernardini N; Bertorelli R; Campanella M; Nicolussi E; Fredduzzi S; Reggiani A
    Eur J Neurosci; 2006 Mar; 23(6):1530-8. PubMed ID: 16553616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.
    Taylor L; Christou I; Kapellos TS; Buchan A; Brodermann MH; Gianella-Borradori M; Russell A; Iqbal AJ; Greaves DR
    Sci Rep; 2015 Jun; 5():10682. PubMed ID: 26033291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
    Kim J; Li Y
    J Physiol; 2015 Feb; 593(4):871-86. PubMed ID: 25504573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats.
    Xu J; Tang Y; Xie M; Bie B; Wu J; Yang H; Foss JF; Yang B; Rosenquist RW; Naguib M
    Eur J Neurosci; 2016 Dec; 44(12):3046-3055. PubMed ID: 27717112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.